About AG Mednet

About AG Mednet

With the increased significance of patient scans as surrogate endpoints in clinical trials, the ability to collect imaging data that meets protocol requirements is more important than ever before.

Ensuring that image data is properly de-identified, case report forms are consistent with the images they complement, and scans meet protocol criteria, are all critical elements necessary to maintain the quality of timepoint submissions.

Enter AG Mednet.

AG Mednet offers the world’s largest 21 CFR Part 11, GCP and HIPAA compliant medical imaging network. Imaging trial sponsors, core labs and clinical research organizations (CROs) collecting imaging time points as part of their trial protocols rely on AG Mednet’s automated system to enhance site compliance, reduce site queries, and enable the secure electronic transfer of scans from thousands of locations around the world while providing the detailed reports necessary to meet the most stringent regulatory requirements.

AG Mednet is the only dedicated electronic image submission and collection provider that offers quality assurance software designed to detect errors at the investigator site – prior to data submission – in order to accelerate clinical trial decision-making. With AG Mednet, sponsors and core laboratories see a measurable reduction in both logistical tasks and trial queries, leading to operating cost reductions and better outcomes.

AG Mednet is the leading quality compliance partner for image data submission and collection for imaging trial sponsors, imaging core labs and clinical research organizations managing clinical trials globally. More than 33,000 registered users across thousands of investigator sites in 70 countries use AG Mednet to participate in projects sponsored by each of the world’s top 20 pharmaceutical, biotech and medical device companies.

Contact us to learn more about how AG Mednet can help automate, expedite and improve outcomes in your imaging intensive clinical trial.

To see how AG Mednet came to be, please view the SlideShare below.